The Commercialization of Genetic Research: Ethical, Legal, and Policy Issues : [proceedings of the Second International Conference on DNA Sampling, Held September 10-13, 1998, in Edmonton, Alberta, Canada]Timothy A. Caulfield, Bryn Williams-Jones Springer Science & Business Media, 31 ธ.ค. 1999 - 200 หน้า The rapid advances made in genetic research and technology over the last few decades have led to a host of important discoveries that have allowed for the detection (and hopefully soon the treatment) of a number of genetic conditions and diseases. Not surprisingly, these advances have also raised numerous ethical concerns about how result ing technologies will be implemented, and the impact they will have on different com munities. One particular concern is the enormous costs involved in conducting genetic research and the fact that the private sector has become heavily involved; the desire to commercialize the results and technology derived from genetic research is considered problematic. In September 1998, the Second International Conference on DNA Sampling, titled "The Commercialization of Genetic Research: Ethical, Legal and Policy Issues," was held of the conference, and of this book, was to in Edmonton, Alberta, Canada. The goal facilitate an interdisciplinary discussion of the legal, ethical, and policy implications arising from the commercialization of genetic research. We solicited contributions for the book from authors in fields as diverse as ethics, law, medicine, health policy, and the social sciences. The papers included, while based on presentations given at the conference, have been substantially expanded and enhanced by the commentary received and discussions held at the conference. |
เนื้อหา
Sovereignty and Sharing | 1 |
National Policies Influencing Innovation based on Human Genetics | 13 |
Intellectual Property Rights and the Human Genome 55 | 55 |
Reintegrating Basic Research Health Policy | 63 |
A Pilot Study | 101 |
Legal and Ethical Considerations | 111 |
Science Risk and International Regulatory Efforts | 129 |
Arguments Used by the Public | 157 |
Patients and Professionals Views on Autonomy Disability | 171 |
Time to Try Private Genetic Services? | 181 |
Contributors | 195 |
ฉบับอื่นๆ - ดูทั้งหมด
The Commercialization of Genetic Research Timothy A Caulfield,Bryn Williams-Jones ไม่มีตัวอย่าง - 1999 |
คำและวลีที่พบบ่อย
academic access to genetic animals Article assess authors benefits Bioethics biomedical research biotech biotechnology companies Canada Caulfield cells clinical trials cloning Committee concerns conflict of interest consent Council Council of Europe debate deCode deCode Genetics disclosure discussion disease drugs European expressed sequence tags federal financial interest funding genes genetic counselling Genetic Research genetic services genetic testing guidelines health care system health sector database human biological materials human genome Huntington Disease Iceland identified impact individual industry infections innovation Institutional Review Boards institutions intellectual property invention involved issues Journal Knoppers license Med Ad medical research Medicine National Nature organs patent applications patent law patent system person physicians potential private access private genetic services professional protection public domain public health regulations regulatory Report risk scientific scientists sequence social technology transfer tion tissue Transplantation University xenografts xenotransplant xenotransplantation